Post-approval studies (Phase 4)Study completedNCT01500278
What this trial is testing
Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
Who this might be right for
Rheumatoid Arthritis
UCB Pharma SA 915